60 related articles for article (PubMed ID: 10455436)
1. A dual specificity promoter system combining cell cycle-regulated and tissue-specific transcriptional control.
Nettelbeck DM; Jérôme V; Müller R
Gene Ther; 1999 Jul; 6(7):1276-81. PubMed ID: 10455436
[TBL] [Abstract][Full Text] [Related]
2. CDF-1 mediated repression of cell cycle genes targets a specific subset of transactivators.
Zwicker J; Lucibello FC; Jérôme V; Brüsselbach S; Müller R
Nucleic Acids Res; 1998 Feb; 26(4):4926-32. PubMed ID: 9729164
[TBL] [Abstract][Full Text] [Related]
3. A transcriptional feedback loop for tissue-specific expression of highly cytotoxic genes which incorporates an immunostimulatory component.
Emiliusen L; Gough M; Bateman A; Ahmed A; Voellmy R; Chester J; Diaz RM; Harrington K; Vile R
Gene Ther; 2001 Jul; 8(13):987-98. PubMed ID: 11438833
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.
Lok CN; Lang AJ; Mirski SE; Cole SP
Biochem J; 2002 Dec; 368(Pt 3):741-51. PubMed ID: 12197834
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of the human Sp1 gene promoter by the specificity protein (Sp) family members nuclear factor Y (NF-Y) and E2F.
Nicolás M; Noé V; Ciudad CJ
Biochem J; 2003 Apr; 371(Pt 2):265-75. PubMed ID: 12513689
[TBL] [Abstract][Full Text] [Related]
7. Chimpanzee, orangutan, mouse, and human cell cycle promoters exempt CCAAT boxes and CHR elements from interspecies differences.
Müller GA; Heissig F; Engeland K
Mol Biol Evol; 2007 Mar; 24(3):814-26. PubMed ID: 17205977
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of the human A-myb promoter: regulation by NF-Y and Sp1.
Facchinetti V; Lopa R; Spreafico F; Bolognese F; Mantovani R; Tavner F; Watson R; Introna M; Golay J
Oncogene; 2000 Aug; 19(34):3931-40. PubMed ID: 10951586
[TBL] [Abstract][Full Text] [Related]
9. GAL4-NF-kappaB fusion protein augments transgene expression from neuronal promoters in the rat brain.
Liu BH; Yang Y; Paton JF; Li F; Boulaire J; Kasparov S; Wang S
Mol Ther; 2006 Dec; 14(6):872-82. PubMed ID: 16904943
[TBL] [Abstract][Full Text] [Related]
10. Modulation of DNA topoisomerase II alpha promoter activity by members of the Sp (specificity protein) and NF-Y (nuclear factor Y) families of transcription factors.
Magan N; Szremska AP; Isaacs RJ; Stowell KM
Biochem J; 2003 Sep; 374(Pt 3):723-9. PubMed ID: 12769819
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional targeting of recombinant adenoviruses to human and murine melanoma cells.
Siders WM; Halloran PJ; Fenton RG
Cancer Res; 1996 Dec; 56(24):5638-46. PubMed ID: 8971169
[TBL] [Abstract][Full Text] [Related]
12. A synthetic leucine zipper-based dimerization system for combining multiple promoter specificities.
Jérôme V; Müller R
Gene Ther; 2001 May; 8(9):725-9. PubMed ID: 11406767
[TBL] [Abstract][Full Text] [Related]
13. Dual transcriptional control of claudin-11 via an overlapping GATA/NF-Y motif: positive regulation through the interaction of GATA, NF-YA, and CREB and negative regulation through the interaction of Smad, HDAC1, and mSin3A.
Lui WY; Wong EW; Guan Y; Lee WM
J Cell Physiol; 2007 Jun; 211(3):638-48. PubMed ID: 17226765
[TBL] [Abstract][Full Text] [Related]
14. Transactivation of the cyclin A promoter by bovine papillomavirus type 4 E5 protein.
Grindlay GJ; Campo MS; O'Brien V
Virus Res; 2005 Mar; 108(1-2):29-38. PubMed ID: 15681052
[TBL] [Abstract][Full Text] [Related]
15. MIA (melanoma inhibitory activity) promoter mediated tissue-specific suicide gene therapy of malignant melanoma.
Schoensiegel F; Paschen A; Sieger S; Eskerski H; Mier W; Rothfels H; Kleinschmidt J; Schadendorf D; Haberkorn U
Cancer Gene Ther; 2004 Jun; 11(6):408-18. PubMed ID: 15118759
[TBL] [Abstract][Full Text] [Related]
16. Expression of the Op18 gene is maintained by the CCAAT-binding transcription factor NF-Y.
Benlhabib H; Herrera JE
Gene; 2006 Aug; 377():177-85. PubMed ID: 16757134
[TBL] [Abstract][Full Text] [Related]
17. Isolation and initial characterization of the BRCA2 promoter.
Davis PL; Miron A; Andersen LM; Iglehart JD; Marks JR
Oncogene; 1999 Oct; 18(44):6000-12. PubMed ID: 10557089
[TBL] [Abstract][Full Text] [Related]
18. Cell-specific regulation of TRBP1 promoter by NF-Y transcription factor in lymphocytes and astrocytes.
Bannwarth S; Lainé S; Daher A; Grandvaux N; Clerzius G; Leblanc AC; Hiscott J; Gatignol A
J Mol Biol; 2006 Feb; 355(5):898-910. PubMed ID: 16343534
[TBL] [Abstract][Full Text] [Related]
19. A strategy for enhancing the transcriptional activity of weak cell type-specific promoters.
Nettelbeck DM; Jérôme V; Müller R
Gene Ther; 1998 Dec; 5(12):1656-64. PubMed ID: 10023445
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter.
Zhu ZB; Makhija SK; Lu B; Wang M; Kaliberova L; Liu B; Rivera AA; Nettelbeck DM; Mahasreshti PJ; Leath CA; Yamamoto M; Alvarez RD; Curiel DT
Gene Ther; 2004 Apr; 11(7):645-8. PubMed ID: 15029227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
